ArticleBioengineering (Basel, Switzerland)2024
Profiling Elastoplastic and Chemical Parameters to Assess Polymerization Quality in Flowable Bulk-Fill Composites.
Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bioactive Fillers in Bulk-Fill Composite Resins: A Comprehensive Review of the Effects on Polymerization Shrinkage Behavior and Mechanical Performance.Materials (Basel, Switzerland) · 2026Review
- Kinetic of Light Transmission during Setting and Aging of Modern Flowable Bulk-Fill Composites.Materials (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the chronology of polymer-based composite materials, flowable bulk-fill composites represent the most recent development. They enable a significant reduction in treatment time by being applied in larger increments of 4 to 5 mm. The aim of the investigation was to assess the polymerization quality and mechanical performance of a new formulation that has just entered the market and was still in experimental formulation at the time of the investigation, and to compare these results in the context of clinically established materials of the same category. Adequate curing in increments of up to 4 mm could be confirmed both by profiling the elastoplastic material behavior of large increments in 100 µm steps and by real-time assessment of the degree of conversion and the associated polymerization kinetic. A slightly lower amount of filler in the experimental material was associated with slightly lower hardness and elastic modulus parameters, but the creep was similar and the elastic and total indentation work was higher. The kinetic parameters were assigned to the specific characteristics of each tested material. The mechanical macroscopic strength, evaluated in a three-point bending test and supplemented by a reliability analysis, met or exceeded the standards and values measured in clinically established materials, which for all materials is related to the higher flexibility of the beams during testing, while the modulus of elasticity was low. The low elastic modulus of all flowable bulk-fill materials must be taken into account when deciding the clinical indication of this material category.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.